- 全部删除
您的购物车当前为空
Acecainide hydrochloride (NAPA) 是 Procainamide 的肝脏主要代谢物,其抗心律失常作用可能导致肾衰竭时的心脏毒性。

Acecainide hydrochloride (NAPA) 是 Procainamide 的肝脏主要代谢物,其抗心律失常作用可能导致肾衰竭时的心脏毒性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 108 | In stock | |
| 5 mg | ¥ 238 | In stock | |
| 10 mg | ¥ 383 | In stock | |
| 25 mg | ¥ 678 | In stock | |
| 50 mg | ¥ 1,130 | In stock | |
| 100 mg | ¥ 1,710 | In stock | |
| 200 mg | ¥ 2,530 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 297 | In stock |
Acecainide hydrochloride 相关产品
| 产品描述 | Acecainide hydrochloride (NAPA) is the major hepatic metabolite of procainamide and its antiarrhythmic effects may lead to cardiotoxicity in renal failure. |
| 别名 | NAPA, ASL 601 |
| 分子量 | 313.83 |
| 分子式 | C15H24ClN3O2 |
| CAS No. | 34118-92-8 |
| Smiles | Cl.CCN(CC)CCNC(=O)c1ccc(NC(C)=O)cc1 |
| 密度 | no data available |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 25 mg/mL (79.66 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
评论内容